$0.309000
-0.0010-0.32%
At close: -
$0.314500
0.00551.78%
After Hours: 5:34 PM EDT
HCW Biologics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of HCW Biologics using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Mar 2024 | 2024-04-01 | $-0.30 | $-0.14 | -114.3 % |
Sep 2023 | 2023-11-14 | $-0.14 | $-0.13 | -7.69 % |
Jun 2023 | 2023-08-11 | $-0.12 | $-0.15 | 20.0 % |
Mar 2023 | 2023-05-09 | $-0.14 | $-0.14 | 0.00 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Mar 2024 | 2024-04-01 | $560.36K | $900.00K | -37.7 % |
Sep 2023 | 2023-11-14 | $853.10K | $300.00K | 184.4 % |
Mar 2023 | 2023-05-09 | $41.88K | $1.15M | -96.4 % |
HCW Biologics (HCWB) is scheduled to report earnings on November 26, 2024. The last reported earnings were for reported on August 14, 2024 for Q2.
The Actual EPS was $-0.40, which missed the estimate of $0.00.
The Actual Revenue was $618.9K, which beat the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.